US biotechnology company Amgen plans to open a Science and Innovation Centre in Hyderabad’s Genome Valley, the company and Telangana government said after signing a memorandum of understanding. The facility is expected to be operational in 2027 and will focus on discovery chemistry, drug metabolism and pharmacokinetics, and precision medicine.
What the centre will do
Amgen said the centre will bring together scientists and technologists across several research areas and will work closely with the company’s research sites worldwide. The firm’s global research and development network consists of seven research laboratories, according to the announcement.
The initiative aims to integrate experimental science, data and technology to complement Amgen’s existing US-based research capabilities. Jay Bradner, Amgen’s executive vice-president of R&D, Artificial Intelligence and Data, said the new centre would help link experimental work with data and technology across Amgen’s global research activities.
“The new centre would contribute to integration of experimental science, data and technology across Amgen global research capabilities and complement the firm’s strong U.S.-based research and development footprint.”
Employment and local impact
The Telangana Minister’s office said the proposed centre will create employment opportunities for around 200 highly skilled professionals. Officials described the move as adding momentum to Hyderabad’s emergence as a global hub for advanced life sciences research.
Telangana’s IT and Industries Minister D. Sridhar Babu welcomed the expansion of global pharmaceutical and biotechnology leaders in the state, saying it reflected growing confidence in local talent, infrastructure and the innovation ecosystem. The minister also urged Amgen to prioritise local youth and talent as the centre develops.
- Location: Genome Valley, Hyderabad
- Expected operational date: 2027
- Planned workforce: about 200 highly skilled professionals
- Research focus: discovery chemistry, drug metabolism and pharmacokinetics, precision medicine
- Corporate context: Amgen’s global R&D network has seven research laboratories
Context within Hyderabad and Telangana
Amgen already expanded its presence in Hyderabad in early 2025, when it opened a global capability centre (GCC) in the city. Telangana officials highlighted Genome Valley’s established ecosystem, skilled workforce and infrastructure as factors that have attracted multinational life sciences and pharmaceutical companies.
Genome Valley is marketed as a dedicated life sciences cluster; hosting international companies there is intended to strengthen local research capabilities and create pathways for new therapies to be developed and taken to market. Officials framed the Amgen centre as part of a broader strategy to position Hyderabad as a destination for advanced life sciences research.
Why this matters
For national and regional science systems, the arrival of an international biotech research centre has several implications:
- It may deepen collaboration between local researchers and global R&D networks, potentially accelerating technology transfer and skills development.
- Creation of specialised jobs can bolster the local talent pipeline in fields such as medicinal chemistry, pharmacokinetics and precision medicine.
- Presence of multinational R&D centres can attract further private and public investment into supporting infrastructure, training and innovation clusters.
These outcomes depend on how the centre is staffed and how it engages with local institutions, including universities, hospitals and smaller biotech firms. Officials have urged Amgen to engage local talent as the centre is established.
| Item | Detail |
|---|---|
| Company | Amgen |
| Site | Genome Valley, Hyderabad |
| Operational target | 2027 |
| Planned jobs | ~200 highly skilled professionals |
| Research areas | Discovery chemistry; drug metabolism and pharmacokinetics; precision medicine |
The announcement is one of several recent moves by global pharmaceutical and biotechnology firms to expand in Telangana. How effectively the new centre integrates with local research talent and infrastructure will determine the scale of its scientific and economic benefits over time.
